← Back to Search

Weight-Loss Program with Mobile Tracking for Obesity

N/A
Waitlist Available
Led By Tiffany Stewart, PhD
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months
Awards & highlights

Study Summary

This trial will test a new weight-loss program that includes mobile tracking of physical activity and nutrition.

Who is the study for?
This trial is for Louisiana National Guard members and their families who are over 18, have a BMI ≥ 25, and aren't due to be deployed for a year. Soldiers must exceed weight/fat limits per Army rules. Participants need smartphone access with daily Wi-Fi and should not be pregnant or unable to read.Check my eligibility
What is being tested?
The H.E.A.L.T.H. II Intervention combines proven strategies tailored for Army Soldiers with remote monitoring tech like mobile devices that track physical activity, weight, and nutrition—aiming to improve health outcomes related to obesity.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication, side effects may include muscle soreness from increased activity or psychological effects such as stress or frustration associated with dietary changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Weight at 6 Months and 12 Months

Trial Design

2Treatment groups
Active Control
Group I: Waitlist Control GroupActive Control1 Intervention
Six month delayed access to the H.E.A.L.T.H. II Intervention - Intensive intervention (wait-list control)
Group II: Active Intervention GroupActive Control1 Intervention
Immediate access to the H.E.A.L.T.H. II Intervention - Intensive intervention

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
304 Previous Clinical Trials
181,356 Total Patients Enrolled
65 Trials studying Obesity
117,565 Patients Enrolled for Obesity
Tiffany Stewart, PhDPrincipal InvestigatorPennington Biomedical Research Center

Media Library

H.E.A.L.T.H. II Intervention Clinical Trial Eligibility Overview. Trial Name: NCT02905422 — N/A
Obesity Research Study Groups: Waitlist Control Group, Active Intervention Group
Obesity Clinical Trial 2023: H.E.A.L.T.H. II Intervention Highlights & Side Effects. Trial Name: NCT02905422 — N/A
H.E.A.L.T.H. II Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT02905422 — N/A
Obesity Patient Testimony for trial: Trial Name: NCT02905422 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Mississippi
What site did they apply to?
Pennington Biomedical Research Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

i want to learn more about obesity and try and help others with the same conditions.
PatientReceived 1 prior treatment
~5 spots leftby Dec 2024